FUGENBIO CO LTD has a total of 34 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are BEN S LAB CO LTD, PERFECT GUANGDONG COMMODITY CO LTD and SHAKLEE CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 17 | |
#2 | United States | 6 | |
#3 | China | 5 | |
#4 | Republic of Korea | 3 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Machines | |
#6 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Foods | |
#3 | Therapeutic chemical compounds | |
#4 | Specific use of cosmetics | |
#5 | Special foods | |
#6 | Microorganisms | |
#7 | Fermentation | |
#8 | Unspecified technologies | |
#9 | Peptides | |
#10 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Kim Yoon Soo | 28 |
#2 | Yoon Sung Kyoon | 14 |
#3 | Shin Eun Ji | 12 |
#4 | Kim Byoung Cheon | 6 |
#5 | Yoo Hye Dong | 5 |
#6 | Park Yong Man | 5 |
#7 | Kim Ji Eun | 3 |
#8 | Kim Na Yeon | 3 |
#9 | Park Yongman | 2 |
#10 | Jeong Eugene | 1 |
Publication | Filing date | Title |
---|---|---|
KR20190003404A | Pharmaceutical composition for treating scar comprising culture medium of ceriporia lacerata | |
KR101900426B1 | Pharmaceutical composition for the prevention or treatment of obesity comprising culture medium of ceriporia lacerata | |
KR101866850B1 | Anti-inflammatory composition comprising submerged culture of ceriporia lacerata mycellium as an active ingredient | |
WO2017026697A1 | Composition containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient for immunoregulation | |
WO2016122261A1 | Pharmaceutical composition for preventing or treating cancer containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient |